Literature DB >> 14578252

Sex differences in the prognostic importance of diabetes in patients with ischemic heart disease undergoing coronary angiography.

Michelle M Graham1, William A Ghali, Peter D Faris, P Diane Galbraith, Colleen M Norris, Merril L Knudtson.   

Abstract

OBJECTIVE: Women with ischemic heart disease have poorer outcomes than men and are suggested to have greater risk associated with diabetes. We evaluated the prognosis associated with diabetes, in analyses stratified by sex, to determine whether similar differences are seen in a large unselected cohort of patients. RESEARCH DESIGN AND METHODS: Using the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH), a clinical data collection and follow-up initiative capturing all patients undergoing cardiac catheterization in Alberta, Canada, the relative significance of diabetes on long-term survival in 13152 men and 4249 women was evaluated in patients presenting with or without myocardial infarction and according to first treatment received.
RESULTS: The 1-year mortality rates were 4.7% and 6.8% in men and women (P < 0.001), 4.1% and 7.4% in nondiabetic and diabetic men (P < 0.001), and 5.8% and 9.6% in nondiabetic and diabetic women, respectively (P < 0.001). The risk-adjusted Cox proportional hazard ratios associated with diabetes in myocardial infarction were 1.03 in men and 1.20 in women. The diabetes hazard ratios for percutaneous coronary intervention were 1.28 in men and 1.40 in women, 1.23 in men and 1.32 in women for bypass surgery, and 1.26 in men and 1.31 in women for medical therapy (P = NS for all diabetes hazard ratio comparisons between men and women).
CONCLUSIONS: Hazard ratios quantifying the adverse prognosis associated with diabetes in patients undergoing angiography are consistently higher among women than men, but the differences across sexes are not statistically significant. These slight sex differences noted in the APPROACH registry are similar to previously reported findings and may be clinically important.

Entities:  

Mesh:

Year:  2003        PMID: 14578252     DOI: 10.2337/diacare.26.11.3142

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  5 in total

1.  Cardiac rehabilitation completion is associated with reduced mortality in patients with diabetes and coronary artery disease.

Authors:  Marni J Armstrong; Ronald J Sigal; Ross Arena; Trina L Hauer; Leslie D Austford; Sandeep Aggarwal; James A Stone; Billie-Jean Martin
Journal:  Diabetologia       Date:  2015-01-26       Impact factor: 10.122

Review 2.  A comprehensive view of sex-specific issues related to cardiovascular disease.

Authors:  Louise Pilote; Kaberi Dasgupta; Veena Guru; Karin H Humphries; Jennifer McGrath; Colleen Norris; Doreen Rabi; Johanne Tremblay; Arsham Alamian; Tracie Barnett; Jafna Cox; William Amin Ghali; Sherry Grace; Pavel Hamet; Teresa Ho; Susan Kirkland; Marie Lambert; Danielle Libersan; Jennifer O'Loughlin; Gilles Paradis; Milan Petrovich; Vicky Tagalakis
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

3.  Cancer and cardiovascular disease: The impact of cardiac rehabilitation and cardiorespiratory fitness on survival.

Authors:  Tamara Williamson; Chelsea Moran; Daniele Chirico; Ross Arena; Cemal Ozemek; Sandeep Aggarwal; Tavis Campbell; Deepika Laddu
Journal:  Int J Cardiol       Date:  2021-09-08       Impact factor: 4.039

Review 4.  Are women with type 2 diabetes mellitus more susceptible to cardiovascular complications following coronary angioplasty?: a meta-analysis.

Authors:  Pravesh Kumar Bundhun; Manish Pursun; Feng Huang
Journal:  BMC Cardiovasc Disord       Date:  2017-07-27       Impact factor: 2.298

5.  Sex-specific outcomes of diabetic patients with acute myocardial infarction who have undergone percutaneous coronary intervention: a register linkage study.

Authors:  Mai Blöndal; Tiia Ainla; Toomas Marandi; Aleksei Baburin; Jaan Eha
Journal:  Cardiovasc Diabetol       Date:  2012-08-11       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.